Status:
COMPLETED
Complications After Epilepsy Surgery
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Epilepsy
Surgery--Complications
Eligibility:
All Genders
Brief Summary
Epilepsy surgery is effective for refractory epilepsy, particularly focal epilepsy, but is still underutilized worldwide. In the United States, the annual percentage of surgical procedures for refract...
Detailed Description
Epilepsy, involving a persistent predisposition to seizure, is one of the most common chronic neurological disorders, affecting more than 65million people worldwide. Epilepsy not only negatively impac...
Eligibility Criteria
Inclusion
- (i) medically refractory epilepsy defined by the International League Against Epilepsyc; (ii) epilepsy surgery performed by a single neurosurgeon, Dr. H.Z.; (iii) surgical procedure performed via craniotomy.
Exclusion
- Patients with neuromodulation therapy were excluded in this study.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
2026 Patients enrolled
Trial Details
Trial ID
NCT04727892
Start Date
October 1 2003
End Date
May 1 2020
Last Update
January 27 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.